COVID-19 Linked To Alzheimer’s-Like Brain Changes, Study Suggests


Authors: Jennifer Margulis via The Epoch Times  For some, it’s just a sniffle. But for others, COVID-19 can hit hard. Either way, some people who get COVID-19 will suffer from long-term effects. This is known as “long COVID,” and its sufferers are often referred to as “long haulers.” Chances are you already know about long COVID and you […]

Did CDC Officials Mislead The Public About COVID Vaccine Efficacy? Rep. Massie Says “Yes”


Via American Greatness, When Congressman Thomas Massie (R-KY) contacted officials from the Centers for Disease Control and Prevention (CDC) in December of 2020, he wanted to know if taking the newly released Covid vaccine would benefit him, since he’d already contracted the illness. After reading the scientific studies himself, and seeing no benefit, Massie contacted […]

The Real Covid Failure


Its superfast spread told us early the virus was unstoppable and likely lab-modified. By Holman W. Jenkins, Jr., June 18, 2024 Wall Street Journal You didn’t think any question related to Covid would be settled in the recent congressional grilling of Anthony Fauci and you were right. That’s why the episode came and went from your news feed […]

Extending Paxlovid Not Effective Against Long COVID


Friday, 07 June 2024 Newsmax Health An extended course of the antiviral drug Paxlovid won’t ease a person’s long COVID symptoms, a new study finds. People who took Paxlovid for 15 days — three times as long as it’s prescribed for an initial COVID infection — had no better improvement in their long COVID than people taking a placebo, […]

Masks Found To Be Ineffective After First Omicron Wave: New Study


MAY 30, 2024 – Authored by Megan Redshaw, J.D. via The Epoch Times  At the onset of the COVID-19 pandemic, masks were a recommended public health measure to prevent transmission of the virus. Yet new research suggests masks were ineffective at reducing the risk of infection when Omicron became the dominant variant. In a study published in […]

Child Mask Mandates Have No Clear Benefits And Cause Harm, BMJ Review Finds


DEC 09, 2023 – Authored by Guy Gin A new systematic review has been published in Archives of Disease in Childhood, one of the journals of the British Medical Journal, by Sandlund et al. titled ‘Child mask mandates for COVID-19: a systematic ‘. Since no randomised controlled trials have even been conducted on child mask-wearing or mask mandates, the […]

Major Oxford-Backed Study Reveals Strict Covid Lockdowns NO MORE EFFECTIVE Than Sweden’s Open-Economy Approach During Pandemic


By Jim Hᴏft Nov. 20, 2023 Gateway Pundit A major study backed by Oxford University has suggested that strict COVID lockdowns were no more effective at reducing infections than the Swedish-style softer approach, which allowed more personal freedom and recommended rather than mandated behaviors aimed at reducing the transmission of the virus. This conclusion challenges the tyrannical […]

The Unexpected Battle Between Vaccines And The COVID Virus


NOV 08, 2023 – Authored by Yuhong Dong The Epoch Times  Since the unprecedented COVID-19 global pandemic that started in January 2020, humans have been in a constant battle with the SARS-CoV-2 virus. A series of vaccine versions have been developed and administered globally, beginning in January 2021 when an mRNA vaccine based on the […]

Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19A Randomized Clinical Trial


Susanna Naggie, MD, MHS1,2; David R. Boulware, MD, MPH3; Christopher J. Lindsell, PhD4; et alThomas G. Stewart, PhD5; Alex J. Slandzicki, MD6; Stephen, C. Lim,  MD Jonathan Cohen, MD8;  David Kavtaradze, MD9,  Arch Amon, MD10, et. al for the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. JAMA. 2023;329(11):888-897. doi:10.1001/jama.2023.1650 Question  Does ivermectin, with a maximum targeted dose of 600 μg/kg daily for 6 days, compared with placebo, shorten symptom duration among adult (≥30 years) outpatients with symptomatic […]

Simvastatin in Critically Ill Patients with Covid-19


November 2, 2023, NEJM Abstract BACKGROUND The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. METHODS In an ongoing international, multifactorial, adaptive platform, randomized, controlled trial, we evaluated simvastatin (80 mg daily) as compared with no statin (control) in critically ill patients with Covid-19 who were not receiving statins […]